cuprizone has been researched along with Optic Neuritis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bose, S; Böser, P; Cui, YF; Fung, E; Huang, L; Klein, C; Kutskova, YA; Memmott, J; Miller, R; Mueller, BK; Popp, A; Tarcsa, E; Veldman, GM | 1 |
1 other study(ies) available for cuprizone and Optic Neuritis
Article | Year |
---|---|
Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models.
Topics: Animals; Cuprizone; Encephalomyelitis, Autoimmune, Experimental; GPI-Linked Proteins; Mice; Monoamine Oxidase Inhibitors; Nerve Regeneration; Nerve Tissue Proteins; Neuroprotection; Optic Nerve; Optic Nerve Injuries; Optic Neuritis; Recovery of Function; Retina; Surface Plasmon Resonance | 2021 |